𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine

✍ Scribed by Takami Sato


Book ID
105968157
Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
243 KB
Volume
43
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Active specific immunotherapy with polyv
✍ Eddy C. Hsueh; Larry Nathanson; Leland J. Foshag; Richard Essner; J. Anne Nizze; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 341 KB πŸ‘ 2 views

## BACKGROUND. This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chronic toxic effects of PMCV treatme

Update on active specific immunotherapy
✍ Conforti, Arnold M.; Ollila, David W.; Kelley, Mark C.; Gammon, Guy; Morton, Don πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

Although a randomized clinical trial has yet to show a statistically significant improvement in the survival of patients receiving vaccine therapy for malignant melanoma, several studies have shown enhanced survival of patients developing an immune response to a melanoma vaccine. The knowledge and t